Abstract

BackgroundOne of the major side effects of Hydroxychloroquine (HCQ) is retinopathy. The aim of this study was to evaluate the Optical coherence tomography angiography (OCTA) parameters in a group of patients who have Hydroxychloroquine-induced retinopathy based on Multifocal electroretinography (mfERG) with a group who do not have retinopathy.MethodThis is a Cross-Sectional Study. In this study, patients with Rheumatoid arthritis (RA) or Systemic lupus erythematosus (SLE) who had been taking Hydroxychloroquine for at least 7 years were included. MfERG and OCTA imaging were performed for all patients. Patients were divided into Normal mfERG and Abnormal mfERG groups based on mfERG results. OCTA parameters were studied in these two groups.ResultSixty-one patients (61 eyes) were included. Forty-one patients had SLE and 20 patients had RA. Forty patients (66.7%) had Abnormal mfERG. The mean vascular density (VD) in Superficial capillary plexus (SCP) layer was not significantly different between Normal mfERG and Abnormal mfERG groups (P-Value> 0.05). Mean VD in SCP layer was not significantly different between Normal mfERG and Abnormal mfERG groups (P-Value> 0.05). In RA subgroup, mean VD in SCP layer in PeriFovea region in Abnormal mfERG group was significantly lower than normal group (P-Value < 0.05). Mean VD in deep capillary plexus (DCP) layer in Whole Image, Superior Hemi, Inferior Hemi, PeriFovea area in Abnormal mfERG group was significantly lower than normal group (P-Value < 0.05). This discrepancy was also observed in the RA subgroup but not in the SLE subgroup. The mean of none of the parameters of foveal avascular zone (FAZ) (mm2), Flow Area of Outer Retina (mm2) and Flow Area of Choriocapillaris (mm2) were not statistically significant between the groups Abnormal mfERG and Normal mfERG. (p-value> 0.05).ConclusionVD in the DCP layer decreased in abnormal mfERG patients compared to patients with normal mfERG. But it seems that VD in SCP layer, FAZ Area and Flow Area are similar in both groups. OCTA may be used as a non-invasive tool in the diagnosis of early stages of HCQ-induced retinopathy, especially in RA patients, but further studies are needed.

Highlights

  • One of the major side effects of Hydroxychloroquine (HCQ) is retinopathy

  • vascular density (VD) in the deep capillary plexus (DCP) layer decreased in abnormal Multifocal electroretinography (mfERG) patients compared to patients with normal mfERG

  • It seems that VD in Superficial capillary plexus (SCP) layer, foveal avascular zone (FAZ) Area and Flow Area are similar in both groups

Read more

Summary

Introduction

One of the major side effects of Hydroxychloroquine (HCQ) is retinopathy. Hydroxychloroquine (HCQ) is an anti-malarial drug that is widely used in the treatment of rheumatic diseases including Systemic lupus erythematosus (SLE) and Rheumatoid arthritis (RA) [1]. An important ocular complication of HCQ is retinal toxicity [2,3,4], the mechanism of which is not well understood. HCQ-induced retinopathy is irreversible and can cause blindness, and may persist even after discontinuation of the drug [8, 9]. The prevalence of this complication at doses less than 5 mg / kg / daily based on real body weight in the first 10 years of drug use is less than 2% [11,12,13]. In more than 10 years of use of the drug and the presence of kidney disease or concomitant use of tamoxifen, it reaches 20% [14]

Objectives
Findings
Methods
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call